✦ 100% Non-Invasive Technology — No Needles. No Incisions. No Compromise. ✦
Medical Solutions

One Photon.
Endless Answers.

Our five proprietary sensor platforms address the most pressing diagnostic and monitoring challenges across oncology, neurology, emergency medicine, wound care, chronic disease, and remote patient monitoring.

14
Clinical Departments Using Our Technology
8,200+
Patients Monitored to Date
67%
Reduction in Lab Test Orders
60%
Healthcare Cost Reduction (Remote Monitoring)
🎗️
Oncology
BioLumin™ BLRI + QuantaFlux™ QSM
Cancer Care

Early Detection &
Recurrence Monitoring

The BioLumin™ Resonance Imaging system detects the unique metabolic signatures of tumour microenvironments non-invasively — identifying cancer recurrence up to 21 days before PET-CT imaging. Paired with QuantaFlux™ mitochondrial mapping, oncologists can continuously track treatment response at the cellular level without repeated biopsies.

Recurrence detected 14–21 days earlier than standard imaging
Real-time chemotherapy response monitoring through the skin
96.3% sensitivity in tumour microenvironment detection
Eliminates need for repeat tissue biopsies during treatment monitoring
Integrated with Princess Margaret Cancer Centre clinical pathways
21Days earlier detection
96.3%Sensitivity
0Contrast agents needed
🧠
Neurology & Neurosurgery
NeuroPulse™ NPOM
Brain Monitoring

Bedside Cortical
Mapping Without MRI

NeuroPulse™ Optical Mapping brings fMRI-level cortical perfusion mapping to the bedside. A lightweight non-contact helmet continuously tracks neural blood-flow dynamics — monitoring stroke progression in real-time, detecting seizure foci, assessing traumatic brain injury severity, and guiding sedation depth in the ICU — all without moving the patient or entering a scan suite.

Full 3D cortical perfusion map every 200 milliseconds
Stroke penumbra identification enabling faster thrombolysis decisions
Continuous seizure monitoring — replaces intermittent EEG in some pathways
Sedation depth quantification for ICU weaning protocols
1mm² spatial resolution — comparable to clinical fMRI
200msMap refresh rate
1mm²Spatial resolution
0MRI scans replaced
🚨
ICU & Emergency Medicine
ChromaDerm™ CDA + QuantaFlux™ QSM
Critical Care

Instant Biochemistry
at the Bedside

In the ICU and emergency department, hours matter. ChromaDerm™ delivers a 47-biomarker biochemical panel in 0.4 seconds — replacing the blood draw and eliminating the 45–90 minute wait for lab results. Paired with QuantaFlux™ metabolic mapping, clinicians detect sepsis onset, organ dysfunction, and coagulopathy in real-time, enabling earlier, more targeted interventions.

47-biomarker panel in 0.4 seconds — no venepuncture required
Sepsis detection via mitochondrial metabolic signature before clinical signs
Continuous lactate, D-dimer, troponin, and creatinine monitoring
67% reduction in routine blood-draw orders in pilot ICU wards
Integration with Epic and Cerner EHR platforms
0.4sFull panel result
47Biomarkers detected
67%Fewer blood draws
🩹
Wound Care & Rehabilitation
PhoTissue™ PWT
Tissue Healing

Diagnose and Heal
in One Session

PhoTissue™ Wave Therapy eliminates the divide between diagnosis and treatment. In a single 8-minute session, it maps wound depth, tissue viability, and inflammatory burden — then delivers precisely calibrated near-infrared photobiomodulation pulses that accelerate cellular repair. Ideal for chronic diabetic ulcers, post-surgical wounds, burns, and pressure injuries.

67% reduction in chronic wound healing time vs. standard care
Real-time wound progress monitoring with every session
Eliminates need for painful debridement probing
Drug-free tissue regeneration via cytochrome c oxidase activation
Cleared for diabetic foot ulcer, burn, and pressure injury pathways
67%Faster wound healing
8 minPer treatment session
0Drugs required
📡
Remote & Home Patient Monitoring
ChromaDerm™ CDA + PhoTissue™ PWT
Digital Health

Hospital-Grade Monitoring
From the Patient's Home

Our wearable sensor patch — powered by ChromaDerm™ technology — continuously streams 47 biomarkers, oxygen saturation, heart rate variability, and tissue metabolic data to clinical dashboards over LTE. Patients with diabetes, heart failure, COPD, and post-surgical recovery are monitored with the same precision as an in-hospital stay, dramatically reducing readmissions and healthcare costs.

Continuous 47-biomarker monitoring, transmitted every 30 seconds
AI-driven anomaly alerts notifying clinical team before patient deterioration
60% reduction in hospital readmission rates for chronic disease patients
Battery life: 7 days continuous monitoring per patch charge
Approved for post-surgical, diabetic, cardiac, and COPD remote pathways
60%Fewer readmissions
7 daysContinuous monitoring
30sData refresh interval

Find the Right Solution
for Your Department

Our clinical implementation team will assess your department's needs and recommend the optimal Advance Med Pro technology pathway.